Phase III evaluating the addition of fulvestrant (F) to anastrozole (A) as adjuvant therapy in postmenopausal women with hormone receptor-positive HER2-negative (HR+/HER2−) early breast cancer (EBC): results from the GEICAM/2006–10 study
Titel:
Phase III evaluating the addition of fulvestrant (F) to anastrozole (A) as adjuvant therapy in postmenopausal women with hormone receptor-positive HER2-negative (HR+/HER2−) early breast cancer (EBC): results from the GEICAM/2006–10 study
Auteur:
Ruíz-Borrego, Manuel Guerrero-Zotano, Angel Bermejo, Begoña Ramos, Manuel Cruz, Josefina Baena-Cañada, Jose Manuel Cirauqui, Beatriz Rodríguez-Lescure, Álvaro Alba, Emilio Martínez-Jáñez, Noelia Muñoz, Montserrat Antolín, Silvia Álvarez, Isabel Del Barco, Sonia Sevillano, Elena Chacón, José Ignacio Antón, Antonio Escudero, María José Ruiz, Victoria Carrasco, Eva Martín, Miguel